Among factors whose mis-regulation has been linked to GBM progression, the cyclin-dependent kinase inhibitor p27Kip1 is an established prognostic marker and its expression has been inversely related to tumor grade and positively related to favorable outcome of GBM patients16, 17. This evidence concerns the gene CDKN1B and glioblastoma.